| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Departments of Neurology*and Pathology,Center for Neurologic Diseases, Brigham and Women’s Hospital, Boston, Massachusetts; the Department of Neurology,Alzheimer’s Disease Research Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; the Department of Physiology and Centre for Neuroscience,Flinders University, Bedford Park, Australia; the Palo Alto Veterans Administration Health Care System,¶Palo Alto, California; the Parkinson’s Institute,**Sunnyvale, California; and the Department of Neurology,||Juntendo University Medical School, Tokyo, Japan
Mutations in 
-synuclein (S) and parkin cause heritable forms of Parkinson disease (PD). We hypothesized that neuronal parkin, a known E3 ubiquitin ligase, facilitates the formation of Lewy bodies (LBs), a pathological hallmark of PD. Here, we report that affinity-purified parkin antibodies labeled classical LBs in substantia nigra sections from four related human disorders: sporadic PD, inherited S-linked PD, dementia with LBs (DLB), and LB-positive, parkin-linked PD. Anti-parkin antibodies also detected LBs in entorhinal and cingulate cortices from DLB brain and S inclusions in sympathetic gangliocytes from sporadic PD. Double labeling with confocal microscopy of DLB midbrain sections revealed that 
90% of anti-S-reactive LBs were also detected by a parkin antibody to amino acids 342 to 353. Accordingly, parkin proteins, including the 53-kd mature isoform, were present in affinity-isolated LBs from DLB cortex. Fluorescence resonance energy transfer and immunoelectron microscopy showed that S and parkin co-localized within brainstem and cortical LBs. Biochemically, parkin appeared most enriched in cytosolic and postsynaptic fractions of adult rat brain, but also in purified, S-rich presynaptic elements that additionally contained parkin’s E2-binding partner, UbcH7. We conclude that parkin and UbcH7 are present with S in subcellular compartments of normal brain and that parkin frequently co-localizes with S aggregates in the characteristic LB inclusions of PD and DLB. These results suggest that functional parkin proteins may be required during LB formation.
This article has been cited by other articles:
 |
|
 |
|
  K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah {alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE J. Biol. Chem., March 14, 2008; 283(11): 6979 - 6987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Klein and M. G. Schlossmacher Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder Neurology, November 27, 2007; 69(22): 2093 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Olzmann, L. Li, M. V. Chudaev, J. Chen, F. A. Perez, R. D. Palmiter, and L.-S. Chin Parkin-mediated K63-linked polyubiquitination targets misfolded DJ-1 to aggresomes via binding to HDAC6 J. Cell Biol., September 7, 2007; 178(6): 1025 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Avraham, R. Rott, E. Liani, R. Szargel, and S. Engelender Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation J. Biol. Chem., April 27, 2007; 282(17): 12842 - 12850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. H. Henn, L. Bouman, J. S. Schlehe, A. Schlierf, J. E. Schramm, E. Wegener, K. Nakaso, C. Culmsee, B. Berninger, D. Krappmann, et al. Parkin Mediates Neuroprotection through Activation of I{kappa}B Kinase/Nuclear Factor-{kappa}B Signaling J. Neurosci., February 21, 2007; 27(8): 1868 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. FORNAI, G. LAZZERI, A. B. DI POGGIO, P. SOLDANI, A. DE BLASI, F. NICOLETTI, S. RUGGIERI, and A. PAPARELLI Convergent Roles of {alpha}-Synuclein, DA Metabolism, and the Ubiquitin-Proteasome System in Nigrostriatal Toxicity. Ann. N.Y. Acad. Sci., August 1, 2006; 1074: 84 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity Hum. Mol. Genet., July 1, 2006; 15(13): 2059 - 2075. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gandhi, M. M. K. Muqit, L. Stanyer, D. G. Healy, P. M. Abou-Sleiman, I. Hargreaves, S. Heales, M. Ganguly, L. Parsons, A. J. Lees, et al. PINK1 protein in normal human brain and Parkinson's disease Brain, July 1, 2006; 129(7): 1720 - 1731. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. St. P. McNaught, T. Jackson, R. JnoBaptiste, A. Kapustin, and C. W. Olanow Proteasomal dysfunction in sporadic Parkinson's disease Neurology, May 23, 2006; 66(10_suppl_4): S37 - S49. [Abstract] [Full Text]
|
|
|
|
|
|
K. M. Rosen, V. Veereshwarayya, C. E-H. Moussa, Q. Fu, M. S. Goldberg, M. G. Schlossmacher, J. Shen, and H. W. Querfurth Parkin Protects against Mitochondrial Toxins and beta-Amyloid Accumulation in Skeletal Muscle Cells J. Biol. Chem., May 5, 2006; 281(18): 12809 - 12816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. W. Smith, Z. Pei, H. Jiang, D. J. Moore, Y. Liang, A. B. West, V. L. Dawson, T. M. Dawson, and C. A. Ross Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration PNAS, December 20, 2005; 102(51): 18676 - 18681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Shin, J. Klucken, C. Patterson, B. T. Hyman, and P. J. McLean The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates {alpha}-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways J. Biol. Chem., June 24, 2005; 280(25): 23727 - 23734. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Smith, R. L. Margolis, X. Li, J. C. Troncoso, M. K. Lee, V. L. Dawson, T. M. Dawson, T. Iwatsubo, and C. A. Ross {alpha}-Synuclein Phosphorylation Enhances Eosinophilic Cytoplasmic Inclusion Formation in SH-SY5Y Cells J. Neurosci., June 8, 2005; 25(23): 5544 - 5552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhong, Y. Tan, A. Zhou, Q. Yu, and J. Zhou RING Finger Ubiquitin-Protein Isopeptide Ligase Nrdp1/FLRF Regulates Parkin Stability and Activity J. Biol. Chem., March 11, 2005; 280(10): 9425 - 9430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sawada, K. Yamakawa, H. Yamakado, R. Hosokawa, M. Ohba, K. Miyamoto, T. Kawamura, and S. Shimohama Cocaine and Phenylephrine Eye Drop Test for Parkinson Disease JAMA, February 23, 2005; 293(8): 932 - 934. [Full Text] [PDF]
|
|
|
|
|
|
A. Yamamoto, A. Friedlein, Y. Imai, R. Takahashi, P. J. Kahle, and C. Haass Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity J. Biol. Chem., February 4, 2005; 280(5): 3390 - 3399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F FORNAI, P LENZI, M GESI, M FERRUCCI, G LAZZERI, L CAPOBIANCO, A DE BLASI, G BATTAGLIA, F NICOLETTI, S RUGGIERI, et al. Similarities between Methamphetamine Toxicity and Proteasome Inhibition Ann. N.Y. Acad. Sci., October 1, 2004; 1025(1): 162 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhou, G. Gu, D. R. Goodlett, T. Zhang, C. Pan, T. J. Montine, K. S. Montine, R. H. Aebersold, and J. Zhang Analysis of {alpha}-Synuclein-associated Proteins by Quantitative Proteomics J. Biol. Chem., September 10, 2004; 279(37): 39155 - 39164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Yao, Z. Gu, T. Nakamura, Z.-Q. Shi, Y. Ma, B. Gaston, L. A. Palmer, E. M. Rockenstein, Z. Zhang, E. Masliah, et al. Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity PNAS, July 20, 2004; 101(29): 10810 - 10814. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Thal, K. Del Tredici, and H. Braak Neurodegeneration in Normal Brain Aging and Disease Sci. Aging Knowl. Environ., June 9, 2004; 2004(23): pe26 - pe26. [Abstract] [Full Text]
|
|
|
|
|
|
M. Tanaka, Y. M. Kim, G. Lee, E. Junn, T. Iwatsubo, and M. M. Mouradian Aggresomes Formed by {alpha}-Synuclein and Synphilin-1 Are Cytoprotective J. Biol. Chem., February 6, 2004; 279(6): 4625 - 4631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J Burn Cortical Lewy body disease J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 175 - 178. [Full Text] [PDF]
|
|
|
|
|
|
R. Bandopadhyay, A. E. Kingsbury, M. R. Cookson, A. R. Reid, I. M. Evans, A. D. Hope, A. M. Pittman, T. Lashley, R. Canet-Aviles, D. W. Miller, et al. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease Brain, February 1, 2004; 127(2): 420 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M.K. Muqit, S. M. Davidson, M. D. Payne Smith, L. P. MacCormac, S. Kahns, P. H. Jensen, N. W. Wood, and D. S. Latchman Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival Hum. Mol. Genet., January 1, 2004; 13(1): 117 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Imai, M. Soda, T. Murakami, M. Shoji, K. Abe, and R. Takahashi A Product of the Human Gene Adjacent to parkin Is a Component of Lewy Bodies and Suppresses Pael Receptor-induced Cell Death J. Biol. Chem., December 19, 2003; 278(51): 51901 - 51910. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. C. Pawlyk, B. I. Giasson, D. M. Sampathu, F. A. Perez, K. L. Lim, V. L. Dawson, T. M. Dawson, R. D. Palmiter, J. Q. Trojanowski, and V. M.-Y. Lee Novel Monoclonal Antibodies Demonstrate Biochemical Variation of Brain Parkin with Age J. Biol. Chem., November 28, 2003; 278(48): 48120 - 48128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. F. Winklhofer, I. H. Henn, P. C. Kay-Jackson, U. Heller, and J. Tatzelt Inactivation of Parkin by Oxidative Stress and C-terminal Truncations: A PROTECTIVE ROLE OF MOLECULAR CHAPERONES J. Biol. Chem., November 21, 2003; 278(47): 47199 - 47208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Cookson, P. J. Lockhart, C. McLendon, C. O'Farrell, M. Schlossmacher, and M. J. Farrer RING finger 1 mutations in Parkin produce altered localization of the protein Hum. Mol. Genet., November 15, 2003; 12(22): 2957 - 2965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Ardley, G. B. Scott, S. A. Rose, N. G. S. Tan, A. F. Markham, and P. A. Robinson Inhibition of Proteasomal Activity Causes Inclusion Formation in Neuronal and Non-Neuronal Cells Overexpressing Parkin Mol. Biol. Cell, November 1, 2003; 14(11): 4541 - 4556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Kim, J. Y. Sung, J. W. Um, N. Hattori, Y. Mizuno, K. Tanaka, S. R. Paik, J. Kim, and K. C. Chung Parkin Cleaves Intracellular {alpha}-Synuclein Inclusions via the Activation of Calpain J. Biol. Chem., October 24, 2003; 278(43): 41890 - 41899. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Huynh, D. R. Scoles, D. Nguyen, and S. M. Pulst The autosomal recessive juvenile Parkinson disease gene product, parkin, interacts with and ubiquitinates synaptotagmin XI Hum. Mol. Genet., October 16, 2003; 12(20): 2587 - 2597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhao, Y. Ren, Q. Jiang, and J. Feng Parkin is recruited to the centrosome in response to inhibition of proteasomes J. Cell Sci., October 1, 2003; 116(19): 4011 - 4019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hishikawa, J.-i. Niwa, M. Doyu, T. Ito, S. Ishigaki, Y. Hashizume, and G. Sobue Dorfin Localizes to the Ubiquitylated Inclusions in Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy, and Amyotrophic Lateral Sclerosis Am. J. Pathol., August 1, 2003; 163(2): 609 - 619. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. J. Dekker, V. Bonifati, and C. M. van Duijn Parkinson's disease: piecing together a genetic jigsaw Brain, August 1, 2003; 126(8): 1722 - 1733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ito, J.-i. Niwa, N. Hishikawa, S. Ishigaki, M. Doyu, and G. Sobue Dorfin Localizes to Lewy Bodies and Ubiquitylates Synphilin-1 J. Biol. Chem., August 1, 2003; 278(31): 29106 - 29114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kahns, M. Kalai, L. D. Jakobsen, B. F. C. Clark, P. Vandenabeele, and P. H. Jensen Caspase-1 and Caspase-8 Cleave and Inactivate Cellular Parkin J. Biol. Chem., June 20, 2003; 278(26): 23376 - 23380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ihara, H. Tomimoto, H. Kitayama, Y. Morioka, I. Akiguchi, H. Shibasaki, M. Noda, and M. Kinoshita Association of the Cytoskeletal GTP-binding Protein Sept4/H5 with Cytoplasmic Inclusions Found in Parkinson's Disease and Other Synucleinopathies J. Biol. Chem., June 20, 2003; 278(26): 24095 - 24102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Corti, C. Hampe, H. Koutnikova, F. Darios, S. Jacquier, A. Prigent, J.-C. Robinson, L. Pradier, M. Ruberg, M. Mirande, et al. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration Hum. Mol. Genet., June 15, 2003; 12(12): 1427 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. C. Tsai, P. S. Fishman, N. V. Thakor, and G. A. Oyler Parkin Facilitates the Elimination of Expanded Polyglutamine Proteins and Leads to Preservation of Proteasome Function J. Biol. Chem., June 6, 2003; 278(24): 22044 - 22055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Snyder, K. Mensah, C. Theisler, J. Lee, A. Matouschek, and B. Wolozin Aggregated and Monomeric alpha -Synuclein Bind to the S6' Proteasomal Protein and Inhibit Proteasomal Function J. Biol. Chem., March 28, 2003; 278(14): 11753 - 11759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Junn, S. S. Lee, U. T. Suhr, and M. M. Mouradian Parkin Accumulation in Aggresomes Due to Proteasome Impairment J. Biol. Chem., November 27, 2002; 277(49): 47870 - 47877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Steece-Collier, E. Maries, and J. H. Kordower Etiology of Parkinson's disease: Genetics and environment revisited PNAS, October 29, 2002; 99(22): 13972 - 13974. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
